Replies to post #559487 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Yes!

The trial design over the years that the study spanned was brilliantly adaptive, compassionate, and clinically appropriate. I wouldn’t have expect anything less from the experts who led the study.






https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847